Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Anandamide amidohydrolase | Starlite/ChEMBL | References |
Homo sapiens | fatty acid amide hydrolase | Starlite/ChEMBL | References |
Homo sapiens | phospholipase A2, group IVA (cytosolic, calcium-dependent) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma japonicum | Fatty-acid amide hydrolase 1, putative | Anandamide amidohydrolase | 579 aa | 499 aa | 24.6 % |
Onchocerca volvulus | Anandamide amidohydrolase | 579 aa | 539 aa | 34.7 % | |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | Anandamide amidohydrolase | 579 aa | 470 aa | 28.3 % |
Leishmania major | hypothetical protein, conserved | fatty acid amide hydrolase | 579 aa | 471 aa | 26.5 % |
Echinococcus granulosus | fatty acid amide hydrolase 1 | Anandamide amidohydrolase | 579 aa | 470 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.1122 | 1 | 0.5 | |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.1122 | 1 | 0.5 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.1122 | 1 | 0.5 |
Onchocerca volvulus | 0.1122 | 1 | 0.5 | |
Schistosoma mansoni | amidase | 0.0246 | 0 | 0.5 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0246 | 0 | 0.5 |
Trypanosoma brucei | fatty acid desaturase, putative | 0.1122 | 1 | 0.5 |
Leishmania major | fatty-acid desaturase, putative | 0.1122 | 1 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0246 | 0 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0246 | 0 | 0.5 |
Leishmania major | stearic acid desaturase, putative | 0.1122 | 1 | 0.5 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.1122 | 1 | 0.5 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.0246 | 0 | 0.5 |
Plasmodium vivax | stearoyl-CoA desaturase (acyl-CoA desaturase, faty acid desaturase), putative | 0.1122 | 1 | 0.5 |
Loa Loa (eye worm) | acyl-CoA desaturase | 0.1122 | 1 | 1 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0246 | 0 | 0.5 |
Plasmodium falciparum | stearoyl-CoA desaturase | 0.1122 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | 0 | Antinociceptive effect in rat at 10 mg/kg, iv by thermal escape test | ChEMBL. | 17459705 |
Activity (functional) | 0 | Antinociceptive effect in rat persistant pain model assessed as suppression of formalin-induced paw flinches at 20 mg/kg, iv relative to control | ChEMBL. | 17459705 |
Activity (functional) | 0 | Antinociceptive effect in rat persistant pain model assessed as suppression of formalin-induced paw flinches at 20 mg/kg, iv in presence of SR141716A | ChEMBL. | 17459705 |
Activity (functional) | 0 | Effect on neuropathic pain in rat chung model assessed as reversal of tactile allodynia at 20 mg/kg, iv | ChEMBL. | 17459705 |
IC50 (binding) | = 1.7 nM | Inhibition of human FAAH expressed in human H4 cells | ChEMBL. | 20036536 |
IC50 (binding) | = 2 nM | Inhibition of human FAAH expressed in H4 cells | ChEMBL. | 17459705 |
IC50 (binding) | = 2 nM | Inhibition of human FAAH expressed in H4 cells | ChEMBL. | 17459705 |
IC50 (binding) | = 2 nM | Inhibition of FAAH | ChEMBL. | 18983142 |
Ki (binding) | = 0.002 uM | Inhibition of rat cortex FAAH by [3H]anandamide carbon filtration assay | ChEMBL. | 19072118 |
Ki (binding) | = 15 uM | Inhibition of cPLA2 activity | ChEMBL. | 17459705 |
Ki (binding) | = 15 uM | Inhibition of cPLA2 activity | ChEMBL. | 17459705 |
Ki (binding) | = 23 uM | Displacement of [3H]CP55940 from CB1 receptor expressed in HEK cells | ChEMBL. | 17459705 |
Ki (binding) | = 23 uM | Displacement of [3H]CP55940 from CB1 receptor expressed in HEK cells | ChEMBL. | 17459705 |
Ki (binding) | = 28 uM | Displacement of [3H]CP55940 from CB2 receptor expressed in CHO cells | ChEMBL. | 17459705 |
Ki (binding) | = 28 uM | Displacement of [3H]CP55940 from CB2 receptor expressed in CHO cells | ChEMBL. | 17459705 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
3 literature references were collected for this gene.